Bicycle Therapeutics (BCYC) Consolidated Net Income (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Consolidated Net Income data on file, last reported at -$60.8 million in Q1 2026.

• For the quarter ending Q1 2026, Consolidated Net Income changed 0.14% year-over-year to -$60.8 million; the trailing twelve-month figure through Mar 2026 stood at -$225.7 million (down 856.59% YoY), and the FY2025 full-year result was -$225.7 million, down 2226.02% from the prior year.
• Consolidated Net Income for Q1 2026 stood at -$60.8 million, down from -$26.8 million in the prior quarter.
• Across five years, Consolidated Net Income topped out at $127.8 million in Q4 2024 and bottomed at -$79.0 million in Q2 2025.
• The 5-year median for Consolidated Net Income is -$39.8 million (2024), against an average of -$33.8 million.
• The widest annual swing landed in 2024, when Consolidated Net Income surged 341.5%; it then plunged 129.1% in 2025.
• A 5-year view of Consolidated Net Income shows it stood at -$32.0 million in 2022, then tumbled by 65.19% to -$52.9 million in 2023, then soared by 341.5% to $127.8 million in 2024, then tumbled by 121.01% to -$26.8 million in 2025, then sank by 126.54% to -$60.8 million in 2026.
• The last three Consolidated Net Income figures came in at -$60.8 million (Q1 2026), -$26.8 million (Q4 2025), and -$59.1 million (Q3 2025), per Business Quant data.

Peer Comparison